... because monitoring the brain matters!
The NeuroWave Team welcomes you. We are dedicated to developing innovative brain monitoring and drug delivery medical devices, powered by state-of-the-art signal processing and control engineering technologies. Our vision is to pioneer automation in anesthesia for improved and safer patient care.
NeuroWave is proud to offer the NeuroSENSE® Monitor, the latest generation of brain monitors for patient-customized anesthesia and sedation delivery.
FeaturedProduct

NeuroSENSE Monitor
The NeuroSENSE is a unique bilateral brain function monitor with simultaneous independent indices of anesthetic effect for each side of the brain that respond instantaneously to changes in patient state. This offers greater insight into the brain of anesthetized or sedated patients and assists clinicians in detecting brain function asymmetry (due to, for example, unilateral pathology) and in making optimal decisions for safer and improved patient care.
RecentNews
- Sep 28, 2021 | NeuroWave Systems Inc. is pleased to announce FDA clearance of New Generation NeuroSENSE Monitor
UpcomingEvents
- Aug 26-29, 2024, Kissimmee, FL | Visit the NeuroWave Systems booth at the Military Health Systems Research Symposium 2024 (MHSRS)!
RecentEvents
- May 17-19, 2024, Seattle, WA | Visitors enjoyed exploring the NeuroWave Systems booth at the International Anesthesia Research Society 2024 Meeting (IARS)!
- May 25-27, 2024, Munich, Germany | Attendees stopped by booth B0.P33 during Euroanaesthesia2024 to view our latest product offerings!
- Apr 27-30, 2024, Toronto, Canada | Society of Cardiovascular Anesthesiologists Meeting (SCA24)
- Mar 3-7, 2024, Suntec City, Singapore | During the 18th World Congress of Anesthesiologists in Singapore, we had the opportunity to showcase the NeuroSENSE monitor to care providers and distributors of the Asian Pacific region!
- Jan 11-14, 2024, Houston, TX | At this year’s STA conference, NeuroWave Systems exhibited the latest product developments and participated in group discussions with STA members, centered around the future of drug infusion technologies.